Masahiro Fujimuro Selected Research

Primary Effusion Lymphoma

3/2022	A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
1/2019	Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression.
1/2019	Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
2/2018	Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
1/2016	Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
8/2014	Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
2/2014	Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
1/2012	The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
12/2011	Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
4/2010	Functional availability of gamma-herpesvirus K-cyclin is regulated by cellular CDK6 and p16INK4a.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Fujimuro Research Topics

Disease

16	Primary Effusion Lymphoma 03/2022 - 01/2003
12	Lymphoma (Lymphomas) 01/2019 - 01/2006
11	Neoplasms (Cancer) 12/2021 - 03/2003
7	Infections 01/2022 - 12/2011
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2004 - 03/2003
1	Epstein-Barr Virus Infections 01/2022
1	Hepatitis 12/2021
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Pain (Aches) 01/2019
1	Starvation 01/2019
1	Neoplasm Metastasis (Metastasis) 11/2010
1	Osteosarcoma (Osteogenic Sarcoma) 11/2010
1	Tetanus 01/2009
1	Necrosis 01/2009
1	Osteomyelitis 01/2009
1	Carcinogenesis 11/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
3	Pharmaceutical PreparationsIBA 12/2021 - 08/2014
3	beta CateninIBA 04/2004 - 03/2003
2	FullerenesIBA 03/2022 - 08/2014
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2003
2	Proteasome InhibitorsIBA 01/2020 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 11/2010
2	Caspase 9IBA 01/2016 - 08/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2009 - 05/2007
2	Glycogen Synthase Kinase 3IBA 08/2005 - 04/2004
2	latency-associated nuclear antigenIBA 07/2003 - 03/2003
2	Glycogen Synthase Kinase 3 betaIBA 07/2003 - 03/2003
1	Viral ProteinsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2020
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2020
1	Capsaicin (Zostrix)FDA Link 01/2019
1	Transcription Factor CHOPIBA 01/2019
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2019
1	sulforaphaneIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Activating Transcription Factor 4IBA 01/2019
1	arctigeninIBA 02/2018
1	methylselenic acidIBA 03/2017
1	Sodium SeleniteIBA 03/2017
1	Selenium CompoundsIBA 03/2017
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2016
1	diallyl trisulfideIBA 01/2016
1	sangivamycinIBA 02/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2012
1	Multifunctional EnzymesIBA 11/2010
1	CytokinesIBA 11/2010
1	Catalytic RNA (Ribozymes)IBA 11/2010
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 11/2010
1	FructoseIBA 11/2010
1	EnzymesIBA 11/2010
1	CyclinsIBA 04/2010
1	Metronidazole (Metric)FDA LinkGeneric 01/2009
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2009
1	UbiquitinIBA 11/2007
1	Small Interfering RNA (siRNA)IBA 01/2006
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2006
1	CaspasesIBA 01/2006
1	Purine NucleosidesIBA 01/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2006
1	AntibodiesIBA 01/2006
1	Glycogen Synthase (Synthase I)IBA 04/2004
1	ChromatinIBA 01/2003
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2003
1	phorbolIBA 01/2003
1	Acetates (Acetic Acid Esters)FDA Link 01/2003

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2009
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
1	Injections 01/2009
1	Radiotherapy 01/2009
1	Organ Transplantation 04/2004